PRTA - Prothena Corporation plc logo

Prothena Corporation plc

PRTA

Prothena Corporation plc is a biotechnology company focused on developing therapies targeting protein dysregulation for neurodegenerative diseases like Alzheimer's and Parkinson's. Its pipeline includes investigational antibodies in various clinical trial phases.

โš•๏ธ Healthcare NASDAQ Listed 2012 $ USD
$1,000 invested 10 years ago โ†’$151today

Score Overview

1 Year
Score
Net Growth81.98%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth463.09%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.1
Net Growth-165.68%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-72.81%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth72.52%
Net Trend50%
Net Income Consistency
Rev Growth51x
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-6.23%
Net Trend50%
Net Income Consistency
Rev Growth20x
Rev Trend50%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Prothena Corporation plc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. PRTA does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 8.25โ€”
1 Year2025-10-22
$ 9.88-16.50%
5 Years2021-10-22
$ 61.61-86.61%
10 Years2016-10-21
$ 54.47-84.85%
All Time2012-12-21
$ 7.2014.58%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 54M-$ 43M$ 288M
2025$ 9M-$ 244M$ 307M
2024$ 135M-$ 122M$ 471M
2023$ 91M-$ 147M$ 618M
2022$ 53M-$ 116M$ 710M
2021$ 200M$ 66M$ 579M
2020$ 853K-$ 111M$ 295M
2019$ 814K-$ 77M$ 375M
2018$ 955K-$ 155M$ 427M
2017$ 27M-$ 153M$ 417M
2016$ 1M-$ 160M$ 386M
2015$ 1M-$ 80M$ 370M
2014$ 50M-$ 7M$ 293M
2013$ 676K-$ 40M$ 176M
IPO2012$ 2M-$ 41M$ 124M
PRTA - Prothena Corporation plc logo

Prothena Corporation plc fundamental performance

Between 2020 and 2025, revenue grew from $ 853K to $ 9M and net income went from -$ 111M to -$ 244M. Revenue increased in 3 of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 1M to $ 9M and net income went from -$ 80M to -$ 244M. Revenue increased in 6 of those 10 years; net income in 5.

Prothena Corporation plc currently holds a 5-year HDB Score of 3.1 out of 10. How the HDB Score is calculated.

Membership

Explore PRTA with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies